Literature DB >> 6214296

Adverse reaction to ipratropium bromide.

C K Connolly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214296      PMCID: PMC1499978          DOI: 10.1136/bmj.285.6346.934

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Sputum viscosity and long-term ipratropium bromide nebuliser therapy.

Authors:  G K Crompton
Journal:  Lancet       Date:  1982-05-29       Impact factor: 79.321

2.  Nebulised ipratropium bromide and salbutamol in chronic bronchitis.

Authors:  A W Lees; G W Allan; J Smith
Journal:  Br J Clin Pract       Date:  1980 Nov-Dec

3.  Comparison of ipratropium bromide and salbutamol by aerosolized solution.

Authors:  C R Jenkins; C M Chow; B L Fisher; G E Marlin
Journal:  Aust N Z J Med       Date:  1981-10

4.  Ipratropium bromide in acute asthma.

Authors:  M J Ward; P H Fentem; W H Smith; D Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21
  4 in total
  12 in total

Review 1.  HRCT imaging of airway responsiveness: effects of anesthetics.

Authors:  R H Brown
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

2.  Adverse reactions to the non-drug constituents of nebuliser solutions.

Authors:  R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

3.  Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion.

Authors:  P Rafferty; R Beasley; P H Howarth; J S Mann; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

4.  Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.

Authors:  J S Mann; P H Howarth; S T Holgate
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

5.  Bronchoconstriction in response to ipratropium bromide.

Authors:  P H Howarth
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-04

6.  Bronchoconstriction in response to ipratropium bromide.

Authors:  K R Patel; W M Tullett
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-23

Review 7.  Physiological perspectives of therapy in bronchial hyperreactivity.

Authors:  L M Pinto Pereira; F A Orrett; M Balbirsingh
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

8.  Effect of ipratropium on nasal reactivity to histamine and eosinophil influx in perennial allergic rhinitis.

Authors:  P Górski; K Pazdrak; U Ruta
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.

Authors:  I G Brown; C S Chan; C A Kelly; A G Dent; P V Zimmerman
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

10.  The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.

Authors:  K A Miszkiel; R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.